[The beneficial action of Navoban during antineoplastic chemotherapy].
Garin
A M
AM
Kupchan
D Z
DZ
Kirsanov
A G
AG
Ivanova
N M
NM
Il'iashenko
V V
VV
D000328:Adult; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003609:Dactinomycin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D009959:Oropharyngeal Neoplasms / Q000150:complications / Q000188:drug therapy; D012074:Remission Induction; D000077526:Tropisetron; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000932:Antiemetics; D007211:Indoles; D001761:Bleomycin; D003609:Dactinomycin; D014747:Vinblastine; D000077526:Tropisetron; D003520:Cyclophosphamide; D002945:Cisplatin